Rishard Weitz, president of Ophthalmic Technologies (OTI), said: “Opko has already made excellent progress in integrating OTI as we have actively worked together over the past months to prepare for the recent market introduction of our breakthrough Spectral SLO OCT system.
“Our team believes there is the potential for powerful synergies between Opko’s therapeutics pipeline and the diagnostic systems and devices used by eye care professionals, and we expect OTI to continue to play an important strategic role in Opko’s plans for a broadly based ophthalmic business.”